For: | Tao ZG, Yuan YX, Wang GW. Long non-coding RNA CDKN2B-AS1 promotes hepatocellular carcinoma progression via E2F transcription factor 1/G protein subunit alpha Z axis. World J Gastrointest Oncol 2023; 15(11): 1974-1987 [PMID: 38077646 DOI: 10.4251/wjgo.v15.i11.1974] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v15/i11/1974.htm |
Number | Citing Articles |
1 |
Songtham Anuntakarun, Jakkrit Khamjerm, Pisit Tangkijvanich, Natthaya Chuaypen. Classification of Long Non-Coding RNAs s Between Early and Late Stage of Liver Cancers From Non-coding RNA Profiles Using Machine-Learning Approach. Bioinformatics and Biology Insights 2024; 18 doi: 10.1177/11779322241258586
|
2 |
Zaifu Zhu, Wei Zhang, Shaohu Huo, Tiantuo Huang, Xi Cao, Ying Zhang. TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1365655
|
3 |
Peng Huang, Feng Wen, Qiu Li. Current concepts of the crosstalk between lncRNA and E2F1: shedding light on the cancer therapy. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1432490
|
4 |
Kuan‐Chun Hsueh, Hsiang‐Lin Lee, Kuo‐Hao Ho, Lun‐Ching Chang, Shun‐Fa Yang, Ming‐Hsien Chien. Disease‐Associated Risk Variants and Expression Levels of the lncRNA, CDKN2B‐AS1, Are Associated With the Progression of HCC. Journal of Cellular and Molecular Medicine 2025; 29(6) doi: 10.1111/jcmm.70496
|